Natalie Walsh

Natalie Walsh has a diverse work experience spanning multiple industries. Natalie currently works as a Stability Team Lead at Allergy Therapeutics since July 2022. From 2019 to 2022, they held the position of Release and Stability Team Lead at EirGen Pharma. Prior to that, Natalie worked as a Senior Scientist at Vistakon Pharmaceuticals, LLC from November 2018 to March 2019. Natalie also worked as an Analytical Scientist at Indivior from October 2016 to October 2018. Before that, they were an Analytical Chemist at Reckitt Benckiser from July 2014 to October 2016. Natalie was also a member of the Royal Society of Chemistry in 2014-2015. Natalie has previous experience in pharmaceutical and forensic analysis from their time at Limerick Institute of Technology (2010-2014) and as a Laboratory Technician at Biomnis Ireland (March 2013-September 2013). Additionally, Natalie worked as a Customer Care Agent at Arise Europe from June 2012 to January 2013.

Natalie Walsh attended the Limerick Institute of Technology from 2010 to 2014, where they earned a Bachelor of Science (BSc) degree in Pharmaceutical and Forensics Analysis. During the same period, they also obtained a Bachelor of Applied Science (B.A.Sc.) degree with a focus on Forensics and Pharmaceuticals from the same institution. Additionally, Natalie obtained a Lean Six Sigma Green Belt Certification from Lean Ireland in January 2021. Furthermore, they hold a Certificate in Lean Six Sigma, specifically Green Belt, from Lean Ireland. Natalie also earned an IOSH Managing Safety certification from LCE Workplace Safety in January 2020. The start and end years for their Lean Ireland certification are not provided.